UpdateBot at 22:29, 16 May 2022

2022-05-16T22:29:41Z

New page

{{short description|Indian pharmaceutical company}}
{{Use Indian English|date=September 2020}}
{{Use dmy dates|date=September 2020}}
{{Infobox company
| name = Divi's Laboratories Limited
| logo = File:Divi's Laboratories Logo.svg
| logo_size = 250px
| logo_alt = Divi's Laboratories' logo
| logo_caption = Divi's Laboratories' logo
| former_name = Divi's Research Centre
| type = [[Public company|Public]]
| traded_as = {{ubl|{{BSE|532488}}|{{NSE|DIVISLAB}}|[[NIFTY 50|NSE NIFTY 50 Constituent]]}}
| ISIN = INE361B01024
| industry = [[Pharmaceuticals]]
| revenue = {{Increase}} {{INRConvert|5584.05|c}} <ref name=ar/>
| revenue_year = 2020
| operating_income = {{Decrease}} {{INRConvert|1819.46|c}} <ref name=ar/>
| income_year = 2020
| net_income = {{Increase}} {{INRConvert|1376.54|c}} <ref name=ar/>
| net_income_year = 2020
| assets = {{Increase}} {{INRConvert|8535.70|c}} <ref name=ar/>
| assets_year = 2020
| equity = {{Increase}} {{INRConvert|7309.92|c}} <ref name=ar/>
| equity_year = 2020
| founded = {{Start date and age|1990|10|12|df=yes|p=yes}}
| hq_location = 1-72/23(P)/DIVIS/303, Divi Towers Cyber Hills, Gachibowli 500032
| hq_location_city = [[Hyderabad]], [[Telangana]]
| hq_location_country = [[India]]
| key_people = {{ubl|Murali Krishna Prasad Divi <small>([[Managing director|MD]])</small>|Satchandra Kiran Divi <small>([[Chief executive officer|CEO]])</small>}}
| products = {{ubl|[[Naproxen]]|[[Gabapentin]]|[[Dextromethorphan HBr]]}}
| owner = {{ubl|Divi Satchandra Kiran (20.34%)|Nilima Motaparti (20.34%)|Divi Swarna Latha (5.27%)|Divis Biotech Private Limited (3.01%)|Murali Krishna Prasad Divi (2.85%)}}
| num_employees = 13,884
| num_employees_year = 2020
| subsid = {{ubl|Divis Laboratories (USA) Inc|Divi’s Laboratories Europe AG}}
| website = {{url|divislabs.com}}
| footnotes = <ref name=ar>{{Cite web|last=Laboratories|first=Divi's|title=Annual Report|url=https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|url-status=live|archive-url=https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|archive-date=18 October 2020|access-date=|website=divislabs.com}}</ref><ref>{{Cite web|last=Inc.|first=Bloomberg|title=Divi's Laboratories Ltd Company profile|url=https://www.bloomberg.com/profile/company/DIVI:IN|url-status=live|archive-url=https://web.archive.org/web/20201018134310/https://www.bloomberg.com/profile/company/DIVI:IN|archive-date=18 October 2020|access-date=2020-09-15|publisher=Bloomberg L.P.}}</ref><ref>{{Cite web|title=Latest Shareholding Pattern - Divi's Laboratories Ltd.|url=https://trendlyne.com/equity/share-holding/336/DIVISLAB/latest/divi-s-laboratories-ltd/|access-date=2020-09-15|website=trendlyne.com|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134307/https://trendlyne.com/equity/share-holding/336/DIVISLAB/latest/divi-s-laboratories-ltd/|url-status=live}}</ref><ref>{{Cite web|last=Laboratories|first=Divi's|title=Subsidiary Financials|url=https://www.divislabs.com/wp-content/uploads/2020/08/Subsidiary-Financials-2020.pdf|url-status=live|archive-url=https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/08/Subsidiary-Financials-2020.pdf|archive-date=18 October 2020|access-date=|website=divislabs.com}}</ref>
}}

'''Divi's Laboratories Limited''' is an [[India|Indian]] [[Multinational corporation|multinational]] [[Medication|Pharmaceuticals]] [[company]] and producer of [[Active ingredient|active pharmaceutical ingredients]] (APIs) and intermediates headquartered in [[Hyderabad]], Telangana, India.<ref>{{Cite web|title=Company Profile-DIVIS LAB|url=https://stock-financials.valuestocks.in/en/divis-lab-company-profile|access-date=2020-09-15|website=Dynamic Levels|language=en-US|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134310/https://stock-financials.valuestocks.in/en/divis-lab-company-profile|url-status=live}}</ref><ref>{{Cite web|title=Company Profile for Divi's Laboratories Ltd|url=https://in.reuters.com/finance/stocks/company-profile/DIVI.BO|access-date=2020-09-15|agency=Reuters|archive-date=18 October 2017|archive-url=https://web.archive.org/web/20171018154537/http://in.reuters.com/finance/stocks/company-profile/DIVI.BO|url-status=dead}}</ref><ref>{{Cite web|last=Inc.|first=Bloomberg|title=Divi's Laboratories Ltd Company profile|url=https://www.bloomberg.com/profile/company/DIVI:IN|url-status=live|archive-url=https://web.archive.org/web/20201018134308/https://www.bloomberg.com/profile/company/DIVI:IN|archive-date=18 October 2020|access-date=2020-09-15|publisher=Bloomberg L.P.}}</ref><ref>{{Cite web|title=DIVI'S LABORATORIES LIMITED - Company, directors and contact details {{!}} Zauba Corp|url=https://www.zaubacorp.com/company/DIVI-S-LABORATORIES-LIMITED/L24110TG1990PLC011854|access-date=2020-09-15|website=www.zaubacorp.com|archive-date=18 October 2020|archive-url=https://web.archive.org/web/20201018134313/https://www.zaubacorp.com/company/DIVI-S-LABORATORIES-LIMITED/L24110TG1990PLC011854|url-status=live}}</ref> The company manufactures and custom synthesizes generic APIs, intermediates and [[nutraceutical]] ingredients.<ref>{{Cite web|title=Top API Manufacturing Company In Hyderabad, India & World {{!}} DivisLabs|url=https://www.divislabs.com/api-manufacturing-company/|access-date=2020-09-15|website=Divis Laboratories World’s largest API manufacturing facility|language=en-US|archive-date=12 August 2020|archive-url=https://web.archive.org/web/20200812025954/https://www.divislabs.com/api-manufacturing-company/|url-status=live}}</ref><ref>{{Cite web|last=Bradstreet|first=Dun|title=Divi's Laboratories company profile|url=https://www.dnb.com/business-directory/company-profiles.divis_laboratories_limited.344527b03327427e0ce523821ee82d40.html|access-date=|website=dnb.com}}</ref> Divi's Laboratories is India's second most valuable [[Medication|pharmaceutical]] company by [[market capitalization]].<ref>{{Cite web|last=Sonavane|first=Ravindra N.|date=2020-08-10|title=Divi's Labs beats drugmakers to become India's 2nd most valuable pharma company|url=https://www.livemint.com/market/mark-to-market/divi-s-labs-share-price-rises-65-becomes-2nd-most-valuable-pharma-company-11597036374437.html|access-date=2020-09-15|website=mint|language=en|archive-date=15 August 2020|archive-url=https://web.archive.org/web/20200815210106/https://www.livemint.com/market/mark-to-market/divi-s-labs-share-price-rises-65-becomes-2nd-most-valuable-pharma-company-11597036374437.html|url-status=live}}</ref>

== History ==
Divi's Laboratories was established in 1990 as Divi's Research Centre. The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.<ref>{{Cite web|title=Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB|url=https://www.moneycontrol.com/company-facts/divislaboratories/history/dl03|access-date=2020-09-17|website=moneycontrol.com|language=en|archive-date=6 June 2020|archive-url=https://web.archive.org/web/20200606223407/https://www.moneycontrol.com/company-facts/divislaboratories/history/DL03|url-status=live}}</ref> Following this, the company established its first Manufacturing facility in 1995 at [[Choutuppal]], [[Telangana]].<ref name=":0">{{Cite web|last=Laboratories|first=Divi's|title=Annual Report|url=https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|url-status=live|archive-url=https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf|archive-date=18 October 2020|access-date=|website=}}</ref> In 2002, the company's second manufacturing facility commenced operations at Chippada near [[Visakhapatnam]].<ref name=":0" />

The company went public with its [[Initial public offering|IPO]] on 17 February 2003.<ref>{{Cite web|date=2003-02-11|title=Divis Labs Fixes Rs 130 Per Share As Floor Price For IPO|url=https://www.financialexpress.com/archive/divis-labs-fixes-rs-130-per-share-as-floor-price-for-ipo/72906/|access-date=2020-09-18|website=The Financial Express|language=en-US|archive-date=17 March 2018|archive-url=https://web.archive.org/web/20180317125855/http://www.financialexpress.com/archive/divis-labs-fixes-rs-130-per-share-as-floor-price-for-ipo/72906/|url-status=live}}</ref><ref>{{Cite web|title=Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB|url=https://www.moneycontrol.com/company-facts/divislaboratories/history/dl03|access-date=2020-09-19|website=moneycontrol.com|language=en|archive-date=6 June 2020|archive-url=https://web.archive.org/web/20200606223407/https://www.moneycontrol.com/company-facts/divislaboratories/history/DL03|url-status=live}}</ref> In 2010, the company established a research centre in [[Hyderabad]].<ref name=":0" />

== Products and services ==

=== Active pharmaceutical ingredients (APIs) and intermediates ===
Divi's Laboratories has between 60-85% global market share in generic [[Naproxen]], [[Dextromethorphan]] and [[Gabapentin]] APIs.<ref>{{Cite web |last=Khandekar |first=Siddhant |last2=Shah |first2=Mitesh |last3=Agarwal |first3=Sudarshan |date=30 May 2021 |title=Divi's Laboratories (DIVLAB) |url=https://www.icicidirect.com/mailimages/IDirect_DivisLab_Q4FY21.pdf |access-date=16 May 2022 |website=ICICI Direct |page=1}}</ref> The company currently has between 20-30% global market share in [[Pregabalin]] and [[Methylamine]] APIs.<ref>{{Cite web |last=Khandekar |first=Siddhant |last2=Shah |first2=Mitesh |last3=Agarwal |first3=Sudarshan |date=30 May 2021 |title=Divi's Laboratories |url=https://www.icicidirect.com/mailimages/IDirect_DivisLab_Q4FY21.pdf |access-date=17 May 2022 |website=ICICI Direct |page=3 |format=PDF}}</ref> The company's API production is backwards integrated.<ref>{{Cite web |last=Sonavane |first=Ravindra N. |date=2020-08-10 |title=Divi's Labs beats drugmakers to become India's 2nd most valuable pharma company |url=https://www.livemint.com/market/mark-to-market/divi-s-labs-share-price-rises-65-becomes-2nd-most-valuable-pharma-company-11597036374437.html |access-date=2022-05-16 |website=mint |language=en}}</ref>

=== Custom synthesis ===
Divi's Laboratories custom synthesis division provides contract development and manufacturing (CDMO) services and contract research and manufacturing services (CRAMS).<ref>{{Cite web |last=Sonavane |first=Ravindra N. |date=2020-08-10 |title=Divi's Labs beats drugmakers to become India's 2nd most valuable pharma company |url=https://www.livemint.com/market/mark-to-market/divi-s-labs-share-price-rises-65-becomes-2nd-most-valuable-pharma-company-11597036374437.html |access-date=2022-05-16 |website=mint |language=en}}</ref> The company's clients include 6 of the top 10 largest multinational pharmaceutical companies.<ref>{{Cite web |last=Jauhari |first=Ujjval |date=2021-02-08 |title=Divi’s Labs’ Dec quarter show is strong but stock remains pricey |url=https://www.livemint.com/market/mark-to-market/divis-laboratories-q3-show-is-strong-but-stock-remains-pricey-11612789870282.html |access-date=2022-05-16 |website=mint |language=en}}</ref>

== Facilities ==
The company has six manufacturing facilities and three R&D centres across India:<ref name=":0" />

=== Manufacturing ===

* [[Choutuppal]] Unit - [[Lingojigudem]] village, Choutuppal mandal, [[Yadadri Bhuvanagiri]] district, [[Telangana]]
* DC SEZ Unit - [[Lingojigudem]] village, Choutuppal mandal, [[Yadadri Bhuvanagiri]] district, [[Telangana]]
* Export Oriented Unit - Chippada village, [[Bheemunipatnam mandal]], [[Visakhapatnam district]], [[Andhra Pradesh]]
* Divi's Pharma SEZ Unit - Chippada village, [[Bheemunipatnam mandal]], [[Visakhapatnam district]], [[Andhra Pradesh]]
* DSN SEZ Unit - Chippada village, [[Bheemunipatnam mandal]], [[Visakhapatnam district]], [[Andhra Pradesh]]
* DCV SEZ Unit - Chippada village, [[Bheemunipatnam mandal]], [[Visakhapatnam district]], [[Andhra Pradesh]]

== References ==
{{reflist}}

{{Nifty 200 companies}}

[[Category:Pharmaceutical companies of India]]
[[Category:Pharmaceutical companies established in 1990]]
[[Category:Indian companies established in 1990]]
[[Category:Manufacturing companies based in Hyderabad, India]]
[[Category:NIFTY 50]]
[[Category:1990 establishments in Andhra Pradesh]]
[[Category:Companies listed on the National Stock Exchange of India]]
[[Category:Companies listed on the Bombay Stock Exchange]]

Divi's Laboratories - Revision history

UpdateBot at 22:29, 16 May 2022